Citation Tools

Download PDFPDF

4CPS-180 Sacituzumab-govitecan in metastatic triple-negative breast cancer: comparison of our data to the ascent trial after 2 years of experience
Free

Download to a citation manager

Cite this article as:
Dho L, Maire A, Levenbruck C, et al
4CPS-180 Sacituzumab-govitecan in metastatic triple-negative breast cancer: comparison of our data to the ascent trial after 2 years of experience